AAL vs CRON

Head-to-Head Stock Analysis & Investment Rating

Last Updated: Sep 13, 2026

AAL

58.4
AI Score
VS
AAL Wins

CRON

48.2
AI Score

Investment Advisor Scores

AAL

58score
Recommendation
HOLD

CRON

48score
Recommendation
HOLD

AI Analyst Insights

AI insights temporarily unavailable

Detailed Metrics Comparison

Metric AAL CRON Winner
Revenue 30.65B 98.22M AAL
Net Income -311.00M 45.84M CRON
Net Margin -1.0% 46.7% CRON
Operating Income 405.00M 5.57M AAL
ROE 7.8% 4.3% AAL
ROA -0.5% 3.9% CRON
Total Assets 64.23B 1.18B AAL
Cash 1.03B 467.02M AAL
Current Ratio 0.53 16.18 CRON

Relative Price Performance (Last 90 Days)

AAL 1M: -12.9% · 3M: -11.2% CRON 1M: -0.9% · 3M: +14.2%

Current Technical Phase

AAL

Markdown
Sell / avoid

Price below a falling SMA50 (slope -5.4%), weak momentum, RSI 37

RSI (14): 37.3 · Price: $13.01

CRON

Neutral
Hold

Mixed signals - no dominant trend phase, RSI 46

RSI (14): 46.3 · Price: $3.14

Fundamentals Snapshot

Metric AAL CRON
Market Cap
Forward P/E 5.7 19.8
Trailing P/E 16.6
Revenue (TTM)
Revenue Growth 0.2% 0.6%
Gross Margin 0.2% 0.4%
Operating Margin 0.0% 0.2%
EPS -0.49 0.19
Dividend Yield

Frequently Asked Questions

Based on our detailed analysis, AAL is currently the stronger investment candidate, winning 5 of the key financial metrics based on our comprehensive scoring model.

We analyze revenue and earnings growth rates in the "Growth" section above. Generally, the company with higher year-over-year revenue and EPS growth is fostering better expansion. Check the table above for the specific growth percentages.

Valuation is determined by metrics like the P/E Ratio and PEG Ratio. A lower P/E typically suggests a stock is cheaper relative to its earnings. Refer to the "Valuation" section in our comparison table to see which stock currently trades at a more attractive multiple.